# HuidaGene

is commercializing the LEAPER (Leveraging Endogenous ADAR for Programmable Editing of RNA) platform from Wei's PKU lab; LEAPER uses a single engineered ADAR-recruiting RNA (arRNA) to direct endogenous ADAR to a target adenosine, with no exogenous enzyme and therefore low immunogenicity and a small delivery payload.

Source: https://en.bioecon.ru/companies/huidagene/
Updated: 2026-07-23

- Country: China

## Technologies

- [RNA editing (ADAR) therapeutics](https://en.bioecon.ru/technology/rna-editing-adar-therapeutics/)